chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed swelling, redness and itching of the right arm, not extending past the right elbow, one day after receiving the second anthrax dose. Received vaccine before departing Turkey.  Presented to local emergency department after returning to CONUS.  Received steroid injection and oral prednisone.
After receiving the Janssen vaccine I endured full body hives, cold sores inside my mouth, and extreme effects to my blood sugar.  I also had jaw swelling that extended up into my cheek.  I  ended up having to make a trip to a medical facility
Patient received flu shot at pharmacy.  When walking out her legs gave out and she fell down.  She was coherent and breathing normally.  EMTs were contacted and she was taken to local ER.  Unknown status after leaving pharmacy.
Several days after vaccination, had a prolonged, multi-day headache. The headache lasted approximately 3 to 4 days following initial symptoms and was treated with OTC pain relievers.
inflamation, pain, restricted motion; rx started w/Motrin, changed to Codeine & APAP, PT;
Feel achy all over; Chills; Low grade fever; Feels tired; This case was reported by a consumer and described the occurrence of pain in a 72-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of heart rate increased (1st dose received on 1st March 2019 and experienced fever and other events, refer case US2019052626).   On 9th September 2019, the patient received the 2nd dose of Shingrix. On 9th September 2019, less than a day after receiving Shingrix, the patient experienced pain, chills, low grade fever and tiredness. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the pain, chills, low grade fever and tiredness were unknown.   It was unknown if the reporter considered the pain, chills, low grade fever and tiredness to be related to Shingrix.  Additional details were received as follows:  In the morning, the patient received Shingrix at around 8 am. The patient noted it was a little under 6 months from his first dose. Later in the day he began to feel achy all over, chills, low grade fever of 98.8 to 99 (which he also had with the first dose) and he feels tired. He has treated the fever with Tylenol. He continued to have the symptoms today.
12JAN91 began running temp, ran temp 12JAN91-15JAN91 ranged from 104-104.8 during that time. no other problems.  Tx w/ Tylenol & sponging.
Flu like symptoms o  8/5/2021 , then tested for COVID result came Positive
CAPT is a 37 y/o JAG office at AFB, who contacted the Vaccine Healthcare Centers network after experiencing adverse events following receipt of the H1N1 vaccine on the morning of 14 Jan 2010. She was well at the time of vaccine receipt; she took no chronic medications except intermittent NSAIDS for musculoskeletal pain and oral contraceptive. On 16 Jan '10 (2 days post vaccine receipt) she became lightheaded and dizzy in the shower. She "greyed out" and slumped to the floor. She was evaluated in the ER and EKG and labs were all normal. While in the ER, it was noted that her heart rate increased by over 30 beats per minute upon standing, with no decreased in blood pressure. This was the day, according to the patient, "that my life changed forever". NOTE: She states in late childhood/adolescene she had sporadic instances where she became lightheaded and dizzy but never passed out. These episodes lasted only 1-2 seconds soon after standing up and quickly resolved. They did not affect her activities and she was able to exercise, run, and dance without symptoms A tilt test in 2010 diagnosed POTS after she had a 30 point increase in HR when going from supine to upright. She since then has developed orthostatic hypotension. CAPT continues with multiple debilitating symptoms affection many body systems for the past 2 years. In spite of numerous diagnostics and special consultations she currently is receiving no effective treatment due to the lack of resources and provider expertise for recognizing, diagnosing and treating this condition. With intervention, she is currently pending a referral and testing at the Dysautonomia Center. Symptoms: Disturbance, sleep, giddiness, Malaise and fatigue, Shortness of breath, Memory loss.
Case number PHEH2013US024581, is an initial spontaneous report received from a health care professional (HCP) on 19 NOV 2013. This report refers to a 46-year-old female patient. Her medical history and concomitant medications were not reported. She ws vaccinated with FLUVIRIN 2013/2014 (batch number: 1308901) at a dose of 0.5 ml into her right deltoid on 10 JUL 2013 at 5:04 PM. On the same day, after vaccination, she experienced itching, redness, soreness, swelling and induration of the injection site. On 10 SEP 2013, she completely recovered from these events. No causality and seriousness of the events was reported.
Headache, dizziness, body ache,  stomach cramps, distress,  nausea
1. Muscular pain at site of injection (trouble lifting arm) - 12/30/20 at 14:30 continuing 2. Mild Chills (Causing Reynaud's to worsen and having trouble returning blood flow back to fingers and toes)- 12/30/20 at 14:30 continuing 3. Body Aches (specifically back and hips) - 12/30/20 at 14:30 continuing 4. Headache - 12/30/20 at 14:30 starting to improve 5. Trouble sleeping  - night of 12/29/20, woke up numerous times during the night  and couldn't fall back asleep after 04:30 on 12/30/20
TONGUE SWELLING, BACK OF THROAT "STARTING TO FEEL FUNNY, NOTICING A CHANGE IN SWALLOWING"  PT WENT TO THE ER FOR ASSESSMENT
Rash from day 10 (itchy). Swollen glands, lymph nodes, sore throat and difficulty swallowing. Fever. Severe joint pain. Adverse effect on milk supply (I am breast feeding). This vaccine should not be taken while breastfeeding.
Patient presented to the ED on 6/27/21 for suicidal risk, agitation. Patient was hospitalized for suicidal ideation on 6/30/21. These visits are within 6 weeks of receiving covid vaccination.
Approx 5 hrs post vaccine - headache, nausea, diarrhea, fatigue Approx 24 hr post vaccine - nausea, fatigue Approx 36 hrs post vaccine - severe nausea, vomiting, diarrhea, unable to keep any liquids or food down
I intitally  was ok, about 1pm I felt a migriane/headache coming on, went home, fell asleep in a hard deep sleep.  woke up felt somewhat better, right arm hurt.   Saturday am woke up and felt kinda unwell, not great but not horrible.  As Saturday evening came on, I developed fever (100.9) , chills and swelling below the injection site.   Joints achy.     As Saturday night progressed I couldn't sleep well, and was still feverish.  I noticed swelling spreading.   Sunday woke up with chills, feeling more unwell, fever, and swelling was all over my upper right side and around to my neck. noticed some burning and radiating discomfort.  Armpit stood out the most as be protruded and puffy.   Monday am, still right upper body side swollen and achy.   sometimes theres a burning but not able to move around with out pain.  Overall not feeling well.
Significant swelling and redness of the right arm, beginning at the armpit and extending down to mid forearm, anterior aspect. Dull pain +6.
Itching on neck that stopped after a few minutes on the day of the vaccine Itching on neck that occurred on subsequent days for a few minutes, usually at night Itching that occurred on  face on subsequent days for a few minutes, usually at night
Started  w cough ~15 min after inj. Cough was progressing, unable to complete sentence w/o cough even after water. Agreed to take Benadryl as stated had had 2 anaphylactic responses when she lived in (-unable to determine that cause). Initail BP 153/91 P71  Recheck BP 145/93 P 69. Coughing decreased after Benadryl 50 mg po. No other sx. Dicussed letting PCP know and possibly premedicate before booster.
About a month later I started having odd symptoms.  I notice changes in my urinary and bowel functions.  Having to void often and more wet bowels on a weekly basis.  Shortly after I started to feel weakness in my thighs and periodically in my upper arms.  Overall weakness and stamina are not normal.  Also considerably fatigued.  Not happening every day but multiple times within a week.  Often 2 to three days feeling like above and 3 to 4 days of somewhat normal but stamina is slowly getting less than before.  Typically I can walk 3 to 4 miles 5 times a week, lift bags for yard work, not get winded on stair.
Pfizer improperly diluted with only 0.8ml diluent. Nurse gave 0.3ml of the vaccine mixutre.
Still feels very tired; I got achy/My lower back ached; I couldn't sleep; My arm hurt/My legs ache; I was extremely thirsty; Chills; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (I got achy/My lower back ached), INSOMNIA (I couldn't sleep), PAIN IN EXTREMITY (My arm hurt/My legs ache), THIRST (I was extremely thirsty) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced BACK PAIN (I got achy/My lower back ached), INSOMNIA (I couldn't sleep), PAIN IN EXTREMITY (My arm hurt/My legs ache), THIRST (I was extremely thirsty), CHILLS (Chills) and HEADACHE (Headache). On 06-Mar-2021, the patient experienced FATIGUE (Still feels very tired). On 06-Mar-2021, HEADACHE (Headache) had resolved. At the time of the report, BACK PAIN (I got achy/My lower back ached), INSOMNIA (I couldn't sleep), PAIN IN EXTREMITY (My arm hurt/My legs ache), THIRST (I was extremely thirsty), CHILLS (Chills) and FATIGUE (Still feels very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Medications were not provided by the reporter.   Reporter did not allow further contact
I have developed severe headaches; congestion; fever; chills; This is a spontaneous report from a contactable consumer or other non hcp reported for himself (patient). A 61-years-old adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine, Solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 23Jul2021 15:00 (Batch/Lot Number: FA7484) (at the age of 61-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and tested for covid post the vaccination. On 27Jul2021, the patient experienced severe headaches, congestion, fever and chills, the patient was unable to return to work and it has lasted for 4 days so far. The patient visited doctor or other healthcare professional office and emergency room. The patient underwent lab tests and procedures which included nasal swab test (sars-cov-2 test): negative on 27Jul2021. The patient not received treatment for events. The outcome of the events was recovering at the time of report.  Follow-Up (24Aug2021): Follow-up attempts are completed. No further information is expected.
Patient who inadvertently recieved 1st dose of Moderna covid 19 vaccine to peson under age 18 was approved by Medical Director Dr to receive 2nd dose of Moderna covid 19 vaccine .
Screaming ongoing since receiving vaccine bilateral thigh areas reddened, induration. Right thigh around 2" area erythema induration. Left thigh minimal redness, induration.
Client or client parents did not report any adverse events, treatments or signs or symptoms upon return to clinic the following day.
This spontaneous report as received from a registered nurse regarding a male patient of unknown age. Pertinent medical history, drug reactions/allergies and concomitant medications were reported as none. On 04-APR-2018 the patient was vaccinated with PNEUMOVAX 23 lot # N030986 with expiry date of 11-MAY-2019 for vaccination (prophylaxis). On 05-APR-2018, the patient was seen at a healthcare center due to complaint of injection site pain at unspecified location (vaccination site pain). The patient had a bright red, warm to touch area over the injection site and streaking on shoulder and axilla along with mild swelling (Adverse event). No laboratory tests were done. Patient received treatment with non-steroidal anti-inflammatory drugs 3 times a day and ice the injection site area. Outcome and causality of the events were not reported. No product quality complaint was involved.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 immunisation.     No Medical History information was reported.   On 27-Feb-2021 at 2:16 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 2:34 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 58.39 for dose administered on 27-Feb-2021 and 58.47 for dose administered on 27-Mar-2021.  No concomitant medications were reported.  Batch number 014M20A administered on 27-Feb-2021 underwent temperature excursion with temperature range of 34 to 35 degrees Fahrenheit from 02:00 pm to 03:00 pm. This vial was moved to fridge on 24-Mar-2021. Product moved to clinic on 27-Feb-2021. Beyond use date for the vial was reported as 26-Mar-2021.  Batch number 019B21A administered on 27-Mar-2021 underwent temperature excursion with temperature of 35 degrees Fahrenheit from 09:00 am to 10: am. This vial was moved to fridge on 23-Mar-2021. Product moved to clinic on 27-Mar-2021. Beyond use date for the vial was reported as 24-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a brand traceable temperature monitor at every hour.  No treatment medications were reported.
hands and feet are like burning on fire; dermatographia that skin raises into welts, swells and inflames; green phlegm; 101 degree of fever; extreme fatigue; sore throat; high heart rate of 140; rash; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), BURNING SENSATION (hands and feet are like burning on fire), MECHANICAL URTICARIA (dermatographia that skin raises into welts, swells and inflames), SPUTUM DISCOLOURED (green phlegm) and HEART RATE INCREASED (high heart rate of 140) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030H21B, 017B21A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Atrial fibrillation (1 episode of atrial fibrillation) in 2015 and COVID-19 on 23-Dec-2020.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), HEART RATE INCREASED (high heart rate of 140), RASH (rash) and HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced BURNING SENSATION (hands and feet are like burning on fire), MECHANICAL URTICARIA (dermatographia that skin raises into welts, swells and inflames), SPUTUM DISCOLOURED (green phlegm), PYREXIA (101 degree of fever) and FATIGUE (extreme fatigue). At the time of the report, OROPHARYNGEAL PAIN (sore throat), BURNING SENSATION (hands and feet are like burning on fire), MECHANICAL URTICARIA (dermatographia that skin raises into welts, swells and inflames), SPUTUM DISCOLOURED (green phlegm), HEART RATE INCREASED (high heart rate of 140), RASH (rash), HYPERSENSITIVITY (allergic reaction), PYREXIA (101 degree of fever) and FATIGUE (extreme fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 degree of fever the first night. On an unknown date, Heart rate: 140 (High) high heart rate of 140. On an unknown date, Streptococcus test: negative (Negative) strep culture turned out negative.         No concomitant medication was reported. The treatment medication were Steroid and Antibiotic.   This case was linked to MOD-2021-435774 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes:
During his 15 minute observation period after receiving his second shot, patient felt ill and started turning pale.  Pharmacy staff came to his side and gave him wet, cold compresses and water.  He was feeling dizzy and clamy but never lost consciousness.  The pharmacist could see that the patient was wearing a CGM.  The patient was able to see his blood glucose levels on his receiver and they were high.  We were able to rule out hypoglycemia.  The patient threw up three times in the waste basket.  After about 20-30 minutes he started feeling better.
pt recvd vax & exp swelling, hardness, pain on pressure @ site of inject; on questioning also stated site was hot to touch; did not seek eval @ time of sx;
Bell's Palsy right face 24 hours after vaccination Treated with prednisone and valtrex
Expired EngerixB administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 40-year-old patient who received HBV (Engerix B) (batch number LG5RN, expiry date 20th August 2022) for prophylaxis.   On 29th August 2022, the patient received Engerix B. On 29th August 2022, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 29-AUG-2022 Reporter's Comments: Office manager reporting an expired dose of Engerix-B was administered on 29th August 2022.  Dose expired on 20th August 2022. The reporter consented to follow up. AE report contains all details provided by HCP.  Additional Supportive Information: The patient was administered with Engerix-B vaccine that was already expired on 20th August 2022.
Vaccine dose number=4; Pfizer/ Vaccine dose number=5; Moderna; COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer). The reporter is the patient. A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in right arm for COVID-19 immunization; elasomeran (MODERNA COVID-19 VACCINE), on 16Sep2022 at 11:00 as dose 5 (booster), single (Batch/Lot number: unknown), in right arm for COVID-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for COVID-19 immunization. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Codeine, reaction(s): "Known allergies: codeine".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Vaccine dose number=4; Pfizer/ Vaccine dose number=5; Moderna". Therapeutic measures were taken as a result of drug ineffective and COVID-19. Clinical information: It was reported that the patient had COVID-19 in 2023 and received PAXLOVID as treatment from 28Feb2023 until 04Mar2023.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Received the flu vaccine at work in the left arm. Within 48 hours after vaccine, a rash appeared on the left lower back.
Patient states 4 hours after his first dose of Pfizer, he developed a rash on his right hand (couple of bumps, per patient). Patient did not take medication for rash and did not consult with HCP. Patient states rash lasted approximately 30 minutes and resolved on its own.
not adverse events. when patient came requesting another vaccination. it was determined that she had already had in fact 3 shingrix shots. 2 were some time back so it did not show up immediately in the patient profile. upon investigation, it was determined she got 3 pneumovax 23 shots over the last few years, 1 prev 13 (which is inappropriate for patient age) and a prev 20 which was completely contraindicated since pt had already had the 23 and 13 . further investigation revealed patient had 5 tdap shots extra since 2016 when she had her tdap shot. from 2016 through 2020. also revealed she had an extra hep a/b shot.
10 minutes after vaccination #1, began with slight headache and the redness of face, arms and chest. No trouble breathing or swallowing. After 45 minutes, slight redness remained and headache had gone.